OTC Markets OTCPK - Delayed Quote
USD
Adaptimmune Therapeutics plc (ADAPY)
0.0200
+0.0010
(+5.26%)
At close: November 6 at 4:00:00 PM EST
Loading chart for ADAPY
- Previous Close
0.0190 - Open
0.0170 - Bid 0.0178 x 1000000
- Ask 0.0199 x 7278600
- Day's Range
0.0170 - 0.0250 - 52 Week Range
0.0010 - 0.0700 - Volume
115,149 - Avg. Volume
202,895 - Market Cap (intraday)
5.301M - Beta (5Y Monthly) 0.83
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6700 - Earnings Date (est.) --
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
-- - Moby Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/7/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
ADAPY
28.57%
MSCI WORLD (^990100-USD-STRD)
6.99%
1-Year Return
ADAPY
41.18%
MSCI WORLD (^990100-USD-STRD)
9.59%
3-Year Return
ADAPY
96.59%
MSCI WORLD (^990100-USD-STRD)
64.16%
5-Year Return
ADAPY
99.63%
MSCI WORLD (^990100-USD-STRD)
0.00%
Earnings Trends
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
425.49%
-
Return on Assets (ttm)
-25.87%
-
Return on Equity (ttm)
-346.65%
-
Revenue (ttm)
5.92M
-
Net Income Avi to Common (ttm)
-78.01M
-
Diluted EPS (ttm)
-0.6700
Balance Sheet and Cash Flow
-
Total Cash (mrq)
25.95M
-
Total Debt/Equity (mrq)
44.05%
-
Levered Free Cash Flow (ttm)
-61.61M
